CereVasc Announces First Patient Randomized to eShunt® System Treatment in STRIDE Pivotal Trial
CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced ...
Endovascular Today3d
CereVasc STRIDE Trial Randomizes First Patient to eShunt System
CereVasc, Inc. announced the randomization of the first patient in the multicenter STRIDE clinical trial of the company’ ...
MassDevice3d
CereVasc randomizes first patient in head-to-head study of eShunt, standard of care
CereVasc today announced the first patient randomized to and treated with the eShunt system in its STRIDE clinical trial.
jnis.bmj3d
Online First
CTA-based deep-learning integrated model for identifying irregular shape and aneurysm size of unruptured intracranial aneurysms ...